世界のECMO市場は、2021年の推定5億3,100万ドルから2026年までに6億7,300万ドルに達し、2021年から2026年までのCAGRは4.9％と予想されます。この市場の成長を推進する主な要因としては、高齢者人口の増加と発症率の増加、ならびに政府の規制、投資、および戦略的取組みが挙げられます。ECMOの利点がその導入に重要な役割を果たしています。速度と精度、および迅速な処理時間によって、以前よりも大幅に多くの患者スクリーニング量が可能になります。これにより、企業は製品開発と技術革新に集中するようになりました。ただし、これらのシステムの価格が高額であるため、導入が遅れています。その他にも、保険償還の減少、特に発展途上国と発展途上国におけるインフラの不備、および放射線被ばくに関連する潜在的なリスクなどの要因が、この市場の成長を妨げる可能性があります。
COVID-19のパンデミックは、2020年の経済に悪影響を及ぼし、世界中の臨床医療提供者と患者にとってさまざまな問題を露呈しました。COVID-19は、ほとんどの国の政府によって課された厳格なロックダウンを主な要因として、、バリューチェーンのさまざまな段階にも影響を与えています。製品やサービスの配送にかかる時間も、国によって課された新しいパッケージングプロトコルとロックダウン措置のために影響を受けています。これら全ての要因が、デジタルX線システムの製造とサプライチェーンに悪影響を及ぼしています。
しかし、COVID-19は、ECMO機械メーカーと医療提供者に新棚事業機会をもたらしました。臨床検査（RT-PCR）が利用できない場合、検査結果が遅れている場合、または最初は陰性である場合、COVID-19が疑われるまたは可能性のある患者に対する代替アプローチとして胸部画像検査が検討されています。WHOによると、胸部X線撮影は、COVID-19肺炎とその合併症の動的評価に役立つ可能性があります。ベッドサイド胸部X線写真で見られる肺硬変の解消または進行は、介護者がより良い治療管理の決定を下すのに役立ちます。胸部画像は、気胸や縦隔気腫の管理においても情報を提供します。
目次
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 20)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKETS SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.5 KEY MARKET STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 23)
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
2.2 MARKET SIZE ESTIMATION METHODOLOGY
2.3 MARKET DATA VALIDATION AND TRIANGULATION
2.4 KEY RESEARCH ASSUMPTIONS
2.5 LIMITATIONS
2.5.1 METHODOLOGY-RELATED LIMITATIONS
2.6 RISK ASSESSMENT
2.7 GROWTH RATE ASSUMPTIONS
2.8 COVID-19 HEALTH ASSESSMENT
2.9 COVID-19 ECONOMIC ASSESSMENT
2.1 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
3 EXECUTIVE SUMMARY (Page No. - 33)
4 PREMIUM INSIGHTS (Page No. - 36)
4.1 ECMO MARKET OVERVIEW
4.2 ECMO MARKET SHARE, BY REGION AND PATIENT TYPE (2020)
4.3 ECMO MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
4.4 ECMO MARKET: GEOGRAPHIC SNAPSHOT
5 MARKET OVERVIEW (Page No. - 42)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing prevalence of cardiovascular and respiratory diseases
5.2.1.2 Growing adoption of ECMO in lung transplantation procedures
5.2.1.3 Growth in the number of ECMO centers
5.2.1.4 Technological advancements in ECMO machines
5.2.2 RESTRAINTS
5.2.2.1 Complications associated with ECMO
5.2.2.2 High cost of ECMO procedures
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing survival rates with ECMO
5.2.4 CHALLENGES
5.2.4.1 Shortage of skilled professionals
5.2.4.2 Eligibility issues for ECMO
5.2.4.3 Issues related to selecting the right equipment
5.2.4.4 Risks related to the transport of ECMO patients
5.2.4.5 Issues related to treatment decision-making
5.3 REGULATORY LANDSCAPE
5.3.1 NORTH AMERICA
5.3.1.1 US
5.3.1.2 Canada
5.3.2 EUROPE
5.3.3 ASIA PACIFIC
5.3.3.1 India
5.3.3.2 Japan
5.3.3.3 China
5.4 COVID-19 IMPACT ON THE ECMO MARKET
5.4.1 REIMBURSEMENT SCENARIO
5.5 PATENT ANALYSIS
5.5.1 PATENTS GRANTED FOR ECMO MACHINES
5.5.2 PUBLICATION TRENDS FOR PATENTS ON ECMO MACHINES
5.6 VALUE CHAIN ANALYSIS
5.7 PRICING TREND ANALYSIS
5.8 PORTER’S FIVE FORCES ANALYSIS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF SUPPLIERS
5.8.4 BARGAINING POWER OF BUYERS
5.8.5 INTENSITY OF COMPETITIVE RIVALRY
5.9 ECOSYSTEM LANDSCAPE
6 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY PRODUCT (Page No. - 60)
6.1 INTRODUCTION
6.2 ECMO MACHINES
6.2.1 STATIC ECMO MACHINES SEGMENT TO DOMINATE THE ECMO MACHINES MARKET
6.2.2 PORTABLE ECMO MACHINES
6.2.3 STATIC ECMO MACHINES
6.3 SOFTWARE
6.3.1 SOFTWARE SEGMENT TO GROW AT A STEADY CAGR DURING THE FORECAST PERIOD
7 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY COMPONENT (Page No. - 69)
7.1 INTRODUCTION
7.2 PUMPS
7.2.1 CENTRIFUGAL BLOOD PUMPS HAVE BECOME THE PUMP OF CHOICE FOR ADULT EXTRACORPOREAL LIFE SUPPORT
7.3 OXYGENATORS
7.3.1 PMP OXYGENATORS HAVE SIGNIFICANTLY LESS PRIMING VOLUME
7.4 CONTROLLERS
7.4.1 CONTROLLERS ALLOW OPERATORS OF ECMO CIRCUITS TO ADJUST THE SETTINGS AS NEEDED
7.5 CANNULAS
7.5.1 THE CHOICE OF CANNULAS IS IMPORTANT IN ECMO PROCEDURES
7.6 ACCESSORIES
8 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY MODALITY (Page No. - 75)
8.1 INTRODUCTION
8.2 VENOARTERIAL ECMO
8.2.1 INCREASING INCIDENCE OF HEART-LUNG FAILURE TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
8.3 VENOVENOUS ECMO
8.3.1 VENOVENOUS ECMO IS USED WHEN ADEQUATE HEART FUNCTION IS AVAILABLE
8.4 ARTERIOVENOUS ECMO
8.4.1 ARTERIOVENOUS ECMO MACHINES ARE SMALLER AND MORE PORTABLE
9 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY PATIENT TYPE (Page No. - 79)
9.1 INTRODUCTION
9.2 NEONATES
9.2.1 A LARGE NUMBER OF NEONATES ARE CARED FOR WITH ECMO WORLDWIDE
9.3 PEDIATRIC PATIENTS
9.3.1 PEDIATRIC PATIENTS FORM A LARGE PATIENT GROUP FOR ECMO PROCEDURES
9.4 ADULTS
9.4.1 TECHNOLOGICAL ADVANCEMENTS ARE DRIVING THE USE OF ECMO IN ADULT PATIENTS
10 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY APPLICATION (Page No. - 83)
10.1 INTRODUCTION
10.2 RESPIRATORY APPLICATIONS
10.2.1 RESPIRATORY APPLICATIONS FOR NEONATES
10.2.2 RESPIRATORY APPLICATIONS FOR PEDIATRIC PATIENTS
10.2.3 RESPIRATORY APPLICATIONS FOR ADULTS
10.3 CARDIAC APPLICATIONS
10.3.1 CARDIAC APPLICATIONS FOR ADULTS
10.3.2 CARDIAC APPLICATIONS FOR PEDIATRIC PATIENTS
10.3.3 CARDIAC APPLICATIONS FOR NEONATES
10.3.4 EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR)
10.3.5 ECPR APPLICATIONS FOR ADULTS
10.3.6 ECPR APPLICATIONS FOR PEDIATRIC PATIENTS
10.4 NEONATES
11 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY REGION (Page No. - 90)
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 US
11.2.1.1 US accounted for the largest share of the North American market
11.2.2 CANADA
11.2.2.1 Implementation of the ABF model in Canadian hospitals to drive market growth
11.3 EUROPE
11.3.1 GERMANY
11.3.1.1 Increasing volume of ECMO procedures to drive market growth in Germany
11.3.2 FRANCE
11.3.2.1 Rising healthcare spending to drive market growth in France
11.3.3 UK
11.3.3.1 Rising adoption of ECMO procedures and increasing prevalence of lifestyle diseases to drive market growth in the UK
11.3.4 ITALY
11.3.4.1 High burden of CVDs contributing to the growth of the ECMO market in Italy
11.3.5 SPAIN
11.3.5.1 High adoption of advanced technologies to drive market growth in Spain
11.4 REST OF EUROPE
11.5 ASIA PACIFIC
11.5.1 JAPAN
11.5.1.1 Favorable healthcare infrastructure in Japan to drive market growth
11.5.2 CHINA
11.5.2.1 Rising geriatric population and increasing prevalence of CVD to drive market growth in China
11.5.3 INDIA
11.5.3.1 Growing applications and rising adoption of ECMO to drive market growth in India
11.5.4 AUSTRALIA
11.5.4.1 Technological advancements to drive market growth in Australia
11.5.5 SOUTH KOREA
11.5.5.1 Increasing incidence of cardiac disorders to drive market growth in South Korea
11.5.6 REST OF APAC
11.6 LATIN AMERICA
11.6.1 BRAZIL
11.6.1.1 Rising adoption of ECMO as a bridge to heart and lung transplantation to drive market growth in Brazil
11.6.2 MEXICO
11.6.2.1 High burden of CVDs in the country to drive market growth in Mexico
11.6.3 REST OF LATIN AMERICA
11.6.4 MIDDLE EAST & AFRICA
11.6.4.1 Increasing prevalence of target diseases to drive market growth in the Middle East & Africa
12 COMPETITIVE LANDSCAPE (Page No. - 118)
12.1 INTRODUCTION
12.2 REVENUE SHARE ANALYSIS
12.3 MARKET SHARE ANALYSIS
12.4 COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2020)
12.4.1 TERMINOLOGY/NOMENCLATURE
12.4.1.1 Stars
12.4.1.2 Emerging leaders
12.4.1.3 Pervasive players
12.4.1.4 Participants
12.5 COMPETITIVE LEADERSHIP MAPPING: START-UP/SME EVALUATION QUADRANT (2020)
12.5.1 PROGRESSIVE COMPANIES
12.5.2 RESPONSIVE COMPANIES
12.5.3 DYNAMIC COMPANIES
12.5.4 STARTING BLOCKS
12.6 COMPETITIVE BENCHMARKING
12.7 COMPETITIVE SCENARIO (2018-2021)
12.7.1 NEW PRODUCT LAUNCHES & APPROVALS
13 COMPANY PROFILES (Page No. - 131)
13.1 KEY PLAYERS
13.1.1 FRESENIUS MEDICAL CARE AG & CO. KGAA
13.1.1.1 Business overview
13.1.1.2 Products offered
13.1.1.3 Recent developments
13.1.1.4 MnM view
13.1.2 GETINGE GROUP
13.1.2.1 Business overview
13.1.2.2 Products offered
13.1.2.3 MnM view
13.1.3 MEDTRONIC PLC
13.1.3.1 Business overview
13.1.3.2 Products offered
13.1.3.3 MnM view
13.1.4 MICROPORT
13.1.4.1 Business overview
13.1.4.2 Products offered
13.1.5 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
13.1.5.1 Business overview
13.1.5.2 Products offered
13.1.5.3 MnM view
13.1.6 NIPRO CORPORATION
13.1.6.1 Business overview
13.1.6.2 Products offered
13.1.7 LIVANOVA PLC
13.1.7.1 Business overview
13.1.7.2 Products offered
13.1.8 EUROSETS S.R.L.
13.1.8.1 Business overview
13.1.8.2 Products offered
13.1.9 ORIGEN BIOMEDICAL, INC.
13.1.9.1 Business overview
13.1.9.2 Products offered
13.1.10 CYTOSORBENTS CORPORATION
13.1.10.1 Business overview
13.1.10.2 Products offered
13.1.11 ABIOMED
13.1.11.1 Business overview
13.1.11.2 Products offered
13.1.12 BRAILE BIOMÉDICA
13.1.12.1 Business overview
13.1.12.2 Products offered
13.1.13 SPECTRUM MEDICAL
13.1.13.1 Business overview
13.1.13.2 Products offered
13.1.14 HAEMONETICS
13.1.14.1 Business overview
13.1.14.2 Products offered
13.1.15 XENIOS AG
13.1.15.1 Business overview
13.1.16 PRODUCTS OFFERED
13.1.16.1 Recent developments
13.1.17 KANEKA CORPORATION
13.1.17.1 Business overview
13.1.17.2 Products offered
13.1.18 SB-KAWASUMI LABORATORIES, INC.
13.1.18.1 Business overview
13.1.18.2 Products offered
13.1.19 WEIGAO GROUP
13.1.19.1 Business overview
13.1.19.2 Products offered
13.1.19.3 Zhengyuan Technology
13.1.20 BUSINESS OVERVIEW
13.1.20.1 Products offered
13.1.21 BREETHE, INC.
13.1.21.1 Business overview
13.1.21.2 Products offered
14 APPENDIX (Page No. - 131)
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 AVAILABLE CUSTOMIZATIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
LIST OF TABLES (171 Tables)
TABLE 1 RISK ASSESSMENT: ECMO MARKET
TABLE 2 NUMBER OF DEATHS FROM CARDIOVASCULAR AND RESPIRATORY DISEASES ACROSS THE GLOBE, 1990 VS. 2019
TABLE 3 GLOBAL INCREASE IN THE NUMBER OF ECMO CENTERS
TABLE 4 AVERAGE COST OF ECMO IN VARIOUS COUNTRIES
TABLE 5 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING THE ECMO MARKET
TABLE 6 CLASSIFICATION OF MEDICAL DEVICES BY US FDA
TABLE 7 CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY IN JAPAN
TABLE 8 NMPA MEDICAL DEVICE CLASSIFICATION
TABLE 9 PATENTS GRANTED FROM 2016 TO 2021
TABLE 10 FILED PATENTS, 2000-2021
TABLE 11 RANTED PATENTS, 2010-2021
TABLE 12 PUBLISHED PATENTS, 2016-2021
TABLE 13 AVERAGE PRICE OF ECMO, BY COUNTRY, 2020 (USD)
TABLE 14 ECMO MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 15 ECMO MARKET, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 16 ECMO MACHINES MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 17 ECMO MACHINES MARKET, BY REGION, 2018-2026 (USD MILLION)
TABLE 18 ECMO MACHINES MARKET, BY COMPONENT, 2018-2026 (USD MILLION)
TABLE 19 ECMO MACHINES MARKET, BY MODALITY, 2018-2026 (USD MILLION)
TABLE 20 ECMO MACHINES MARKET, BY PATIENT TYPE, 2018-2026 (USD MILLION)
TABLE 21 ECMO MACHINES MARKET, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 22 PORTABLE ECMO MACHINES MARKET, BY REGION, 2018-2026 (USD MILLION)
TABLE 23 PORTABLE ECMO MACHINES MARKET, BY MODALITY, 2018-2026 (USD MILLION)
TABLE 24 PORTABLE ECMO MACHINES MARKET, BY PATIENT TYPE, 2018-2026 (USD MILLION)
TABLE 25 PORTABLE ECMO MACHINES MARKET, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 26 STATIC ECMO MACHINES MARKET, BY REGION, 2018-2026 (USD MILLION)
TABLE 27 STATIC ECMO MACHINES MARKET, BY COMPONENT, 2018-2026 (USD MILLION)
TABLE 28 STATIC ECMO MACHINES MARKET, BY MODALITY, 2018-2026 (USD MILLION)
TABLE 29 STATIC ECMO MACHINES MARKET, BY PATIENT TYPE, 2018-2026 (USD MILLION)
TABLE 30 STATIC ECMO MACHINES MARKET, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 31 ECMO SOFTWARE MARKET, BY REGION, 2018-2026 (USD MILLION)
TABLE 32 ECMO SOFTWARE MARKET, BY MODALITY, 2018-2026 (USD MILLION)
TABLE 33 ECMO SOFTWARE MARKET, BY PATIENT TYPE, 2018-2026 (USD MILLION)
TABLE 34 ECMO SOFTWARE MARKET, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 35 ECMO MARKET, BY COMPONENT, 2018-2026 (USD MILLION)
TABLE 36 ECMO MARKET FOR PUMPS, BY REGION, 2018-2026 (USD MILLION)
TABLE 37 ECMO MARKET FOR OXYGENATORS, BY REGION, 2018-2026 (USD MILLION)
TABLE 38 ECMO MARKET FOR CONTROLLERS, BY REGION, 2018-2026 (USD MILLION)
TABLE 39 ECMO MARKET FOR CANNULAS, BY REGION, 2018-2026 (USD MILLION)
TABLE 40 ECMO MARKET FOR ACCESSORIES, BY REGION, 2018-2026 (USD MILLION)
TABLE 41 ECMO MARKET, BY MODALITY, 2018-2026 (USD MILLION)
TABLE 42 VENOARTERIAL ECMO MARKET, BY REGION, 2018-2026 (USD MILLION)
TABLE 43 VENOVENOUS ECMO MARKET, BY REGION, 2018-2026 (USD MILLION)
TABLE 44 ARTERIOVENOUS ECMO MARKET, BY REGION, 2018-2026 (USD MILLION)
TABLE 45 COMMON INDICATIONS FOR ECMO IN NEONATES, PEDIATRIC PATIENTS, AND ADULTS
TABLE 46 ECMO MARKET, BY PATIENT TYPE, 2018-2026 (USD MILLION)
TABLE 47 ECMO MARKET FOR NEONATES, BY REGION, 2018-2026 (USD MILLION)
TABLE 48 ECMO MARKET FOR PEDIATRIC PATIENTS, BY REGION, 2018-2026 (USD MILLION)
TABLE 49 ECMO MARKET FOR ADULTS, BY REGION, 2018-2026 (USD MILLION)
TABLE 50 ECMO MARKET, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 51 ECMO MARKET FOR RESPIRATORY APPLICATIONS, BY REGION, 2018-2026 (USD MILLION)
TABLE 52 NUMBER OF NEONATES RECEIVING ECMO SUPPORT FOR RESPIRATORY APPLICATIONS
TABLE 53 NUMBER OF PEDIATRIC PATIENTS RECEIVING ECMO SUPPORT FOR RESPIRATORY APPLICATIONS
TABLE 54 NUMBER OF ADULTS RECEIVING ECMO SUPPORT FOR RESPIRATORY APPLICATIONS
TABLE 55 ECMO MARKET FOR CARDIAC APPLICATIONS, BY REGION, 2018-2026 (USD MILLION)
TABLE 56 ECMO MARKET FOR ECPR APPLICATIONS, BY REGION, 2018-2026 (USD MILLION)
TABLE 57 ECMO MARKET, BY REGION, 2018-2026 (USD MILLION)
TABLE 58 NORTH AMERICA: ECMO MARKET, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 59 NORTH AMERICA: ECMO MARKET, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 60 NORTH AMERICA: ECMO MACHINES MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 61 NORTH AMERICA: ECMO MARKET, BY COMPONENT, 2018-2026 (USD MILLION)
TABLE 62 NORTH AMERICA: ECMO MARKET, BY MODALITY, 2018-2026 (USD MILLION)
TABLE 63 NORTH AMERICA: ECMO MARKET, BY PATIENT TYPE, 2018-2026 (USD MILLION)
TABLE 64 NORTH AMERICA: ECMO MARKET, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 65 US: ECMO MARKET, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 66 US: ECMO MACHINES MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 67 CANADA: ECMO MARKET, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 68 CANADA: ECMO MACHINES MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 69 EUROPE: ECMO MARKET, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 70 EUROPE: ECMO MARKET, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 71 EUROPE: ECMO MACHINES MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 72 EUROPE: ECMO MARKET, BY COMPONENT, 2018-2026 (USD MILLION)
TABLE 73 EUROPE: ECMO MARKET, BY MODALITY, 2018-2026 (USD MILLION)
TABLE 74 EUROPE: ECMO MARKET, BY PATIENT TYPE, 2018-2026 (USD MILLION)
TABLE 75 EUROPE: ECMO MARKET, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 76 GERMANY: ECMO MARKET, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 77 GERMANY: ECMO MACHINES MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 78 FRANCE: ECMO MARKET, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 79 FRANCE: ECMO MACHINES MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 80 UK: ECMO MARKET, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 81 UK: ECMO MACHINES MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 82 ITALY: ECMO MARKET, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 83 ITALY: ECMO MACHINES MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 84 SPAIN: ECMO MARKET, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 85 SPAIN: ECMO MACHINES MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 86 REST OF EUROPE: ECMO MARKET, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 87 REST OF EUROPE: ECMO MACHINES MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 88 ASIA PACIFIC: ECMO MARKET, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 89 ASIA PACIFIC: ECMO MARKET, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 90 ASIA PACIFIC: ECMO MACHINES MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 91 ASIA PACIFIC: ECMO MARKET, BY COMPONENT, 2018-2026 (USD MILLION)
TABLE 92 ASIA PACIFIC: ECMO MARKET, BY MODALITY, 2018-2026 (USD MILLION)
TABLE 93 ASIA PACIFIC: ECMO MARKET, BY PATIENT TYPE, 2018-2026 (USD MILLION)
TABLE 94 ASIA PACIFIC: ECMO MARKET, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 95 JAPAN: ECMO MARKET, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 96 JAPAN: ECMO MACHINES MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 97 CHINA: ECMO MARKET, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 98 CHINA: ECMO MACHINES MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 99 INDIA: ECMO MARKET, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 100 INDIA: ECMO MACHINES MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 101 AUSTRALIA: ECMO MARKET, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 102 AUSTRALIA: ECMO MACHINES MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 103 SOUTH KOREA: ECMO MARKET, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 104 SOUTH KOREA: ECMO MACHINES MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 105 REST OF APAC: ECMO MARKET, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 106 REST OF APAC: ECMO MACHINES MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 107 LATIN AMERICA: ECMO MARKET, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 108 LATIN AMERICA: ECMO MARKET, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 109 LATIN AMERICA: ECMO MACHINES MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 110 LATIN AMERICA: ECMO MARKET, BY COMPONENT, 2018-2026 (USD MILLION)
TABLE 111 LATIN AMERICA: ECMO MARKET, BY MODALITY, 2018-2026 (USD MILLION)
TABLE 112 LATIN AMERICA: ECMO MARKET, BY PATIENT TYPE, 2018-2026 (USD MILLION)
TABLE 113 LATIN AMERICA: ECMO MARKET, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 114 BRAZIL: ECMO MARKET, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 115 BRAZIL: ECMO MACHINES MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 116 MEXICO: ECMO MARKET, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 117 MEXICO: ECMO MACHINES MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 118 REST OF LATIN AMERICA: ECMO MARKET, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 119 REST OF LATIN AMERICA: ECMO MACHINES MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 120 MIDDLE EAST & AFRICA: ECMO MARKET, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 121 MIDDLE EAST & AFRICA: ECMO MACHINES MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 122 MIDDLE EAST & AFRICA: ECMO MARKET, BY COMPONENT, 2018-2026 (USD MILLION)
TABLE 123 MIDDLE EAST & AFRICA: ECMO MARKET, BY MODALITY, 2018-2026 (USD MILLION)
TABLE 124 MIDDLE EAST & AFRICA: ECMO MARKET, BY PATIENT TYPE, 2018-2026 (USD MILLION)
TABLE 125 MIDDLE EAST & AFRICA: ECMO MARKET, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 126 PRODUCT FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ECMO MARKET
TABLE 127 APPLICATION FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ECMO MARKET
TABLE 128 COMPANY FOOTPRINT ANALYSIS IN THE ECMO MARKET
TABLE 129 FRESENIUS MEDICAL CARE AG & CO. KGAA: BUSINESS OVERVIEW
TABLE 130 FRESENIUS MEDICAL CARE AG & CO. KGAA: PRODUCT OFFERINGS
TABLE 131 PRODUCT LAUNCHES
TABLE 132 GETINGE GROUP: BUSINESS OVERVIEW
TABLE 133 GETINGE GROUP: PRODUCT OFFERINGS
TABLE 134 MEDTRONIC PLC: BUSINESS OVERVIEW
TABLE 135 MEDTRONIC PLC: PRODUCT OFFERINGS
TABLE 136 MICROPORT: BUSINESS OVERVIEW
TABLE 137 MICROPORT: PRODUCT OFFERINGS
TABLE 138 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: BUSINESS OVERVIEW
TABLE 139 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: PRODUCT OFFERINGS
TABLE 140 NIPRO CORPORATION: BUSINESS OVERVIEW
TABLE 141 NIPRO CORPORATION: PRODUCT OFFERINGS
TABLE 142 LIVANOVA PLC.: BUSINESS OVERVIEW
TABLE 143 LIVANOVA PLC.: BUSINESS OVERVIEW
TABLE 144 LIVANOVA PLC: PRODUCT OFFERINGS
TABLE 145 EUROSETS S.R.L.: BUSINESS OVERVIEW
TABLE 146 EUROSETS S.R.L.: PRODUCT OFFERINGS
TABLE 147 ORIGEN BIOMEDICAL, INC.: BUSINESS OVERVIEW
TABLE 148 ORIGEN BIOMEDICAL, INC.: PRODUCT OFFERINGS
TABLE 149 CYTOSORBENTS CORPORATION: BUSINESS OVERVIEW
TABLE 150 CYTOSORBENTS CORPORATION: PRODUCT OFFERINGS
TABLE 151 ABIOMED: BUSINESS OVERVIEW
TABLE 152 ABIOMED: PRODUCT OFFERINGS
TABLE 153 BRAILE BIOMÉDICA: BUSINESS OVERVIEW
TABLE 154 BRAILE BIOMÉDICA: PRODUCT OFFERINGS
TABLE 155 SPECTRUM MEDICAL: BUSINESS OVERVIEW
TABLE 156 SPECTRUM MEDICAL: PRODUCT OFFERINGS
TABLE 157 HAEMONETICS: BUSINESS OVERVIEW
TABLE 158 HAEMONETICS: PRODUCT OFFERINGS
TABLE 159 XENIOS AG: BUSINESS OVERVIEW
TABLE 160 XENIOS AG: PRODUCT OFFERINGS
TABLE 161 PRODUCT LAUNCHES
TABLE 162 KANEKA CORPORATION: BUSINESS OVERVIEW
TABLE 163 KANEKA CORPORATION: PRODUCT OFFERINGS
TABLE 164 SB-KAWASUMI LABORATORIES, INC.: BUSINESS OVERVIEW
TABLE 165 SB-KAWASUMI: PRODUCT OFFERINGS
TABLE 166 WEIGAO GROUP: BUSINESS OVERVIEW
TABLE 167 WEIGAO GROUP: PRODUCT OFFERINGS
TABLE 168 ZHENGYUAN TECHNOLOGY: BUSINESS OVERVIEW
TABLE 169 ZHENGYUAN TECHNOLOGY: PRODUCT OFFERINGS
TABLE 170 BREETHE, INC.: BUSINESS OVERVIEW
TABLE 171 BREETHE, INC.: PRODUCT OFFERINGS
LIST OF FIGURES (37 Figures)
FIGURE 1 ECMO MARKET SEGMENTATION
FIGURE 2 RESEARCH DESIGN
FIGURE 3 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 4 DATA TRIANGULATION METHODOLOGY
FIGURE 5 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 6 RECOVERY SCENARIO OF THE GLOBAL ECONOMY (2021-2022)
FIGURE 7 ECMO MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 8 ECMO MARKET SHARE, BY MODALITY, 2021 VS. 2026
FIGURE 9 ECMO MARKET, BY COMPONENT, 2021 VS. 2026 (USD MILLION)
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE ECMO MARKET
FIGURE 11 RISING PREVALENCE OF TARGET DISEASES TO DRIVE MARKET GROWTH
FIGURE 12 NORTH AMERICA DOMINATED THE ECMO MARKET IN 2020
FIGURE 13 ECMO MACHINES SEGMENT WILL CONTINUE TO DOMINATE THE ECMO MARKET DURING THE FORECAST PERIOD
FIGURE 14 EMERGING MARKETS ARE ESTIMATED TO REGISTER HIGHER GROWTH RATES THAN DEVELOPED MARKETS
FIGURE 15 ECMO MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 16 VALUE CHAIN OF THE ECMO MARKET
FIGURE 17 THREAT OF NEW ENTRANTS
FIGURE 18 THREAT OF SUBSTITUTES
FIGURE 19 BARGAINING POWER OF SUPPLIERS
FIGURE 20 BARGAINING POWER OF BUYERS
FIGURE 21 INTENSITY OF COMPETITIVE RIVALRY
FIGURE 22 ECMO MARKET: ECOSYSTEM LANDSCAPE
FIGURE 23 NORTH AMERICA: ECMO MARKET SNAPSHOT
FIGURE 24 ASIA PACIFIC: ECMO MARKET SNAPSHOT
FIGURE 25 KEY DEVELOPMENTS BY LEADING PLAYERS IN THE ECMO MARKET, 2018-2021
FIGURE 26 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE ECMO MARKET
FIGURE 27 ECMO MARKET SHARE, BY KEY PLAYER, 2020
FIGURE 28 ECMO MARKET: DEGREE OF COMPETITION
FIGURE 29 ECMO MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
FIGURE 30 ECMO MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS, 2020
FIGURE 31 FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY SNAPSHOT
FIGURE 32 GETINGE GROUP: COMPANY SNAPSHOT
FIGURE 33 MEDTRONIC PLC: COMPANY SNAPSHOT
FIGURE 34 MICROPORT: COMPANY SNAPSHOT
FIGURE 35 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: COMPANY SNAPSHOT
FIGURE 36 NIPRO CORPORATION: COMPANY SNAPSHOT
FIGURE 37 LIVANOVA PLC.: COMPANY SNAPSHOT
